GREY:MDCGF - Post Discussion
Post by
brianpeart on Oct 11, 2012 2:40pm
Stage III steps
A press release Sept 25 says:
Medicago grants PMP an exclusive license to develop, commercialize and manufacture Medicago's pandemic and seasonal influenza vaccines for China. In addition, Medicago has signed an exclusive, worldwide license for a portfolio of plant-based protein development technologies from PM.
Does this impact the reporting? In any case it would seem to provide evidence the methodolgy is accepted.
Be the first to comment on this post